Author/Creator: Shockley, Abigail - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Shockley, Abigail

1. Idecabtagene vicleucel versus ciltacabtagene autoleucel: a Sophie's choice for patients with relapsed refractory multiple myeloma. Issue 6 (3rd June 2022)

Authors:: Davis, James; McGann, Mary; Shockley, Abigail; Hashmi, Hamza
Journal:: Expert review of hematology
Issue:: Volume 15:Issue 6(2022)
Page Start:: 473
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma. (April 2022)

Authors:: Davis, James A.; Shockley, Abigail; Glode, Ashley E.
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 28:Number 3(2022)
Page Start:: 686
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant. (October 2022)

Authors:: Shockley, Abigail; Davis, James A; Gaffney, Kelly J; Smith, Deidra; Weeda, Erin; Hashmi, Hamza
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 28:Number 7(2022)
Page Start:: 1613
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma. (June 2022)

Authors:: Davis, James A.; Shockley, Abigail; Hashmi, Hamza
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 28:Number 4(2022)
Page Start:: 960
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗